xRapid
X Rapid Group is a biotech startup focused on improving people's lives through AI applications. They leverage artificial intelligence to develop innovative solutions in healthcare, particularly in mobile health diagnostics. Their key product is an automated test for malaria diagnosis, which can be deployed in various field conditions. The company aims to expand its capabilities to detect other diseases, positioning itself as a leader in the health tech market with significant potential for growth and impact.
xRapid
X Rapid Group is a biotech startup focused on improving people's lives through AI applications. They leverage artificial intelligence to develop innovative solutions in healthcare, particularly in mobile health diagnostics. Their key product is an automated test for malaria diagnosis, which can be deployed in various field conditions. The company aims to expand its capabilities to detect other diseases, positioning itself as a leader in the health tech market with significant potential for growth and impact.
TL;DR
Sector: Biotechnology / Health diagnostics (AI-powered mobile diagnostics)
Founded: 2015
Headquarters: Aix-en-Provence, France
Founders / Key leadership: Jean Viry-Babel (CEO), David Mendels (Co‑founder / CTO)
Last reported funding stage: Series A
Company Overview
Problem Domain
Point-of-care infectious disease diagnosis using AI on mobile platforms.
Founded
2015
Industry
Biotechnology
Tech Stack
Funding Track Record
600000
Crunchbase lists Series A as last recorded round; profile references Charles-Edouard Bouee as an investor.
Investor Signal
“Charles-Edouard Bouee”